Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd Stock price
Equities
600671
CNE000000BF3
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.96 CNY | -0.99% | +2.40% | -23.16% |
Sales 2021 | 147M 20.37M | Sales 2022 | 109M 15.08M | Capitalization | 1.16B 160M |
---|---|---|---|---|---|
Net income 2021 | -29M -4.02M | Net income 2022 | -67M -9.28M | EV / Sales 2021 | 8.06 x |
Net Debt 2021 | 91.41M 12.66M | Net Debt 2022 | 73.65M 10.2M | EV / Sales 2022 | 11.3 x |
P/E ratio 2021 |
-37.4
x | P/E ratio 2022 |
-17.3
x | Employees | 371 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.72% |
1 day | -0.99% | ||
1 week | +2.40% | ||
Current month | -1.10% | ||
1 month | -0.55% | ||
3 months | -26.01% | ||
6 months | -7.44% | ||
Current year | -23.16% |
Managers | Title | Age | Since |
---|---|---|---|
Xu Yu Xu
CEO | Chief Executive Officer | 46 | 23-09-26 |
Hong Jian Yu
DFI | Director of Finance/CFO | 46 | 23-09-26 |
Guo Jun Dang
BRD | Director/Board Member | 37 | 21-05-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hua Cheng
BRD | Director/Board Member | 55 | 91-12-31 |
Guo Jun Dang
BRD | Director/Board Member | 37 | 21-05-25 |
Hong Jian Yu
DFI | Director of Finance/CFO | 46 | 23-09-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 8.96 | -0.99% | 531,100 |
24-03-27 | 9.05 | +4.02% | 1,310,500 |
24-03-26 | 8.7 | +0.93% | 285,101 |
24-03-25 | 8.62 | -0.58% | 430,801 |
24-03-22 | 8.67 | -0.91% | 727,800 |
End-of-day quote Shanghai S.E., March 27, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-23.16% | 151M | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |